Literature DB >> 23458418

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Switzerland: sampling only invasive isolates does not allow a representative description of the local diversity of clones.

L Senn1, P Basset, G Greub, G Prod'hom, R Frei, R Zbinden, V Gaia, C Balmelli, G E Pfyffer, K Mühlemann, G Zanetti, D S Blanc.   

Abstract

We conducted a molecular study of MRSA isolated in Swiss hospitals, including the first five consecutive isolates recovered from blood cultures and the first ten isolates recovered from other sites in newly identified carriers. Among 73 MRSA isolates, 44 different double locus sequence typing (DLST) types and 32 spa types were observed. Most isolates belonged to the NewYork/Japan, the UK-EMRSA-15, the South German and the Berlin clones. In a country with a low to moderate MRSA incidence, inclusion of non-invasive isolates allowed a more accurate description of the diversity. ©2013 The Authors Clinical Microbiology and Infection ©2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23458418     DOI: 10.1111/1469-0691.12185

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  2 in total

1.  Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.

Authors:  William L Kelley; Ambre Jousselin; Christine Barras; Emmanuelle Lelong; Adriana Renzoni
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

2.  Clinical and molecular characteristics of invasive community-acquired Staphylococcus aureus infections in Chinese children.

Authors:  Yanhong Qiao; Xue Ning; Qiang Chen; Ruizhen Zhao; Wenqi Song; Yuejie Zheng; Fang Dong; Shipeng Li; Juan Li; Lijuan Wang; Ting Zeng; Yanhong Dong; Kaihu Yao; Sangjie Yu; Yonghong Yang; Xuzhuang Shen
Journal:  BMC Infect Dis       Date:  2014-11-07       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.